OpenAlexOpen AccessOpen Access
Gastrointestinal Presentation in COVID-19 in Indonesia: A Case Report.
Muhammad Khifzhon Azwar, Fauzia Kirana, Adi Lukas Kurniawan, Sri Wahyu Handayani, Siti Setiati
Terbit
2020
sitasi
20
Bahasa
en
Penulis
5
Abstrak
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently causing a widespread infection in the world. During the pandemic, physicians may need to raise the index of suspicion earlier in at-risk patients presenting with gastrointestinal symptoms, which are uncommon findings in coronavirus disease 2019 (COVID-19) patients. We report a patient in Indonesia with chest pain and gastrointestinal symptoms who was later confirmed to have SARS-CoV-2 infection after spending days of hospitalisation in the standard ward.
Sitasi
Azwar, M. K., Kirana, F., Kurniawan, A. L., Handayani, S. W., Setiati, S. (2020). Gastrointestinal Presentation in COVID-19 in Indonesia: A Case Report.. *PubMed*. https://doaj.org/article/30296f1dc0a447a09c99fc61b1af1ff3
— Terkait
Penelitian terkait
Open AccessCrossrefOpenAlexOpen Access2020
Mental health care for medical staff in China during the COVID-19 outbreak
Qiongni Chen, Mining Liang, Yamin Li, Jincai Guo, Dongxue Fei et al.
The Lancet Psychiatry · Elsevier BV
OutbreakCoronavirus disease 2019 (COVID-19)ChinaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Open AccessCrossrefOpenAlexOpen Access2020
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, Raymond Liu, Tom Wai‐Hin Chung et al.
The Lancet · Elsevier BV
MedicineLopinavirRitonavirRibavirin
Open AccessCrossrefOpenAlexOpen Access2020
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
Ahmet Kürşat Azkur, Mübeccel Akdiş, Dilek Azkur, Milena Sokołowska, Willem van de Veen et al.
Allergy · Wiley
As a zoonotic disease that has already spread globally to several million human beings and possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID-19) appears practically impossible. There is a pressing need to improve our understanding of the immunology of this disease to contain the pandemic by developing vaccines and medicines for the prevention and treatment of patients. In this review, we aim to improve our understanding on the immune response and immunopathological changes in patients linked
ImmunologyMedicineViral pneumoniaImmune system
Open AccessCrossrefOpenAlexOpen Access2020
Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units
Majid Assadi, Ali Gholamrezanezhad, Narges Jokar, Mohsen Keshavarz, Maria Picchio et al.
European Journal of Nuclear Medicine and Molecular Imaging · Springer Science+Business Media
PandemicCoronavirus disease 2019 (COVID-19)Preparedness2019-20 coronavirus outbreak
Open AccessCrossrefOpenAlexOpen Access2021
Interplay between inflammation and thrombosis in cardiovascular pathology
Konstantin Stark, Steffen Maßberg
Nature Reviews Cardiology · Nature Portfolio
MedicineInflammationThrombosisIntensive care medicine
Open AccessCrossrefOpenAlexOpen Access2020
Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know
Sonja A. Rasmussen, John C. Smulian, John A. Lednicky, Tony Wen, Denise J. Jamieson
American Journal of Obstetrics and Gynecology · Elsevier BV
MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)